An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

Blockbuster weight-loss shots like Ozempic, Wegovy and Victoza may have an unexpected side effect impacting as many as ...

Biocon shares are in focus as the company has received regulatory approval from the Central Drugs Standard Control Organisation for its diabetes drug, Liraglutide, in India. The approval is for a ...

Victoza For Weight loss Victoza is occasionally prescribed as an injectable medication for weight loss, targeting individuals with elevated BMIs. Its mechanism involves stimulating hormones that ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that are allowed to be compounded. Read more here.

However, the cost of Victoza and Saxenda is at least $500 (about 730,000 won) per month, which is half the price of Ozempic and Wegovy, both of which exceed $1,000 (about 1,450,000 won) per month.

Diabetes drug Victoza, or liraglutide, is a first generation GLP-1, a class of treatments that has seen overwhelming demand. It has been on the FDA’s shortage list since 2023, and currently ...

Victoza (liraglutide) solution for injection is prescribed to help manage blood sugar and reduce major heart-related risks. Victoza is not safe to use while pregnant and may not be safe to use ...

Novo Nordisk's Victoza, a popular diabetes medication, has shown mixed results in a mid-stage trial targeting Alzheimer's disease. While the drug failed to meet its primary endpoint of improving ...

The first-ever generic GLP-1 medication — a duplicate version of Teva Pharmaceuticals' Victoza — was launched on June 25. Doctors explain the potential benefits for diabetes patients.